Current status of polypharmacy in patients with chronic kidney disease

Current status of polypharmacy in patients with chronic kidney disease - Current status of polypharmacy in patients with chronic kidney disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000030126

Enrollment

100

Registered

2017-11-27

Start date

2015-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease(CKD)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: CKD patients who are regularly prescribed medication in our hospital

Exclusion criteria

Exclusion criteria: Patients complicated with serious diseases such as malignancy, heart failure (NYHA III degrees or more), hematological disorder, and liver cirrhosis

Design outcomes

Primary

Measure	Time frame
Pharmacokinetic and psychological effects of polypharmacy on CKD patients	—

Secondary

Measure	Time frame
Effects of improvement of polypharmacy on kidney function of CKD patients	—

Countries

Japan

Contacts

Public ContactMatsukura Matsukura

Saitama Tsukinomori Clinic Division of Pharmacy

matsukura@k-naika-cl.jp048-792-1811

Outcome results